BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38452697)

  • 1. Paris polyphylla ethanol extract and polyphyllin I ameliorate adenomyosis by inhibiting epithelial-mesenchymal transition.
    Shi YX; Xu L; Wang X; Zhang KK; Zhang CY; Liu HY; Ding PP; Shi W; Liu ZY
    Phytomedicine; 2024 May; 127():155461. PubMed ID: 38452697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyphyllin I inhibits invasion and epithelial-mesenchymal transition via CIP2A/PP2A/ERK signaling in prostate cancer.
    Liu X; Sun Z; Deng J; Liu J; Ma K; Si Y; Zhang T; Feng T; Liu Y; Tan Y
    Int J Oncol; 2018 Sep; 53(3):1279-1288. PubMed ID: 29956727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyphyllin I inhibits growth and invasion of cisplatin-resistant gastric cancer cells by partially inhibiting CIP2A/PP2A/Akt signaling axis.
    Zhang Y; Huang P; Liu X; Xiang Y; Zhang T; Wu Y; Xu J; Sun Z; Zhen W; Zhang L; Si Y; Liu Y
    J Pharmacol Sci; 2018 Jul; 137(3):305-312. PubMed ID: 30119963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyphyllin I Overcomes EMT-Associated Resistance to Erlotinib in Lung Cancer Cells via IL-6/STAT3 Pathway Inhibition.
    Lou W; Chen Y; Zhu KY; Deng H; Wu T; Wang J
    Biol Pharm Bull; 2017 Aug; 40(8):1306-1313. PubMed ID: 28515374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyphyllin II inhibits human bladder cancer migration and invasion by regulating EMT-associated factors and MMPs.
    Niu W; Xu L; Li J; Zhai Y; Sun Z; Shi W; Jiang Y; Ma C; Lin H; Guo Y; Liu Z
    Oncol Lett; 2020 Sep; 20(3):2928-2936. PubMed ID: 32782609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of Polyphyllin I-induced apoptosis and reversal of the epithelial-mesenchymal transition in human osteosarcoma cells.
    Chang J; Wang H; Wang X; Zhao Y; Zhao D; Wang C; Li Y; Yang Z; Lu S; Zeng Q; Zimmerman J; Shi Q; Wang Y; Yang Y
    J Ethnopharmacol; 2015 Jul; 170():117-27. PubMed ID: 25978954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of polyphyllins I and VII on human cisplatin-resistant NSCLC via p53 upregulation and CIP2A/AKT/mTOR signaling axis inhibition.
    Feng FF; Cheng P; Sun C; Wang H; Wang W
    Chin J Nat Med; 2019 Oct; 17(10):768-777. PubMed ID: 31703757
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Liu Z; Sun Z; Zhang D; Ma C; Jiang Y; Cao G; Sun C; Li K; Xu D; Liu J; Zhao S
    Transl Cancer Res; 2020 Oct; 9(10):5994-6004. PubMed ID: 35117211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyphyllin I and VII potentiate the chemosensitivity of A549/DDP cells to cisplatin by enhancing apoptosis, reversing EMT and suppressing the CIP2A/AKT/mTOR signaling axis.
    Feng F; Cheng P; Wang C; Wang Y; Wang W
    Oncol Lett; 2019 Nov; 18(5):5428-5436. PubMed ID: 31612051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyphyllin I induces autophagy and cell cycle arrest via inhibiting PDK1/Akt/mTOR signal and downregulating cyclin B1 in human gastric carcinoma HGC-27 cells.
    He J; Yu S; Guo C; Tan L; Song X; Wang M; Wu J; Long Y; Gong D; Zhang R; Cao Z; Li Y; Peng C
    Biomed Pharmacother; 2019 Sep; 117():109189. PubMed ID: 31387191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dioscin suppresses TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration and invasion.
    Lim WC; Kim H; Kim YJ; Choi KC; Lee IH; Lee KH; Kim MK; Ko H
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3342-3348. PubMed ID: 28610976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paris polyphylla saponins II inhibits invasive, migration and epithelial-mesenchymal transition of melanoma cells through activation of autophagy.
    Cheng H; Chu J; Yang Y; Li Y; Wang M; Wu H; Wang M; Su J; Li Q
    Toxicon; 2024 Jan; 237():107558. PubMed ID: 38072315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network Pharmacology and Experimental Evidence Reveal Dioscin Suppresses Proliferation, Invasion, and EMT via AKT/GSK3b/mTOR Signaling in Lung Adenocarcinoma.
    Mao W; Yin H; Chen W; Zhao T; Wu S; Jin H; Du B; Tan Y; Zhang R; He Y
    Drug Des Devel Ther; 2020; 14():2135-2147. PubMed ID: 32546976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Nutritional Status on the Absorption of Polyphyllin I, an Anticancer Candidate from Paris polyphylla in Rats.
    Yu FL; Gong WL; Xu FJ; Wu JW; Shakya S; Zhu H
    Eur J Drug Metab Pharmacokinet; 2018 Oct; 43(5):587-597. PubMed ID: 29589340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of FOXO3 pathway is involved in polyphyllin I-induced apoptosis and cell cycle arrest in human bladder cancer cells.
    Li J; Ma W; Cheng X; Zhang X; Xie Y; Ji Z; Wu S
    Arch Biochem Biophys; 2020 Jul; 687():108363. PubMed ID: 32335049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of polyphyllin D, a steroidal saponin in Paris polyphylla, in growth inhibition of human breast cancer cells and in xenograft.
    Lee MS; Yuet-Wa JC; Kong SK; Yu B; Eng-Choon VO; Nai-Ching HW; Chung-Wai TM; Fung KP
    Cancer Biol Ther; 2005 Nov; 4(11):1248-54. PubMed ID: 16258257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyphyllin I activates AMPK to suppress the growth of non-small-cell lung cancer via induction of autophagy.
    Wu Y; Si Y; Xiang Y; Zhou T; Liu X; Wu M; Li W; Zhang T; Xiang K; Zhang L; Zhao H; Liu Y
    Arch Biochem Biophys; 2020 Jul; 687():108285. PubMed ID: 32074500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Talin1 Induces Epithelial-Mesenchymal Transition to Facilitate Endometrial Cell Migration and Invasion in Adenomyosis Under the Regulation of microRNA-145-5p.
    Wang YY; Duan H; Wang S; Quan YJ; Huang JH; Guo ZC
    Reprod Sci; 2021 May; 28(5):1523-1539. PubMed ID: 33537874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyphyllin I suppresses human osteosarcoma growth by inactivation of Wnt/β-catenin pathway in vitro and in vivo.
    Chang J; Li Y; Wang X; Hu S; Wang H; Shi Q; Wang Y; Yang Y
    Sci Rep; 2017 Aug; 7(1):7605. PubMed ID: 28790389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRTC2 activates the epithelial-mesenchymal transition of diabetic kidney disease through the CREB-Smad2/3 pathway.
    Li Y; Zhang Y; Shi H; Liu X; Li Z; Zhang J; Wang X; Wang W; Tong X
    Mol Med; 2023 Oct; 29(1):146. PubMed ID: 37884902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.